claim
Posted by will
•
June 29, 2026, 9:01 AM
Relying on low marginal costs might undermine pharmaceutical innovation, as companies may lack incentives to invest in new drug development.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!